SCHEMBL7609417

SCHEMBL7609417

O=C(NCc1ccc(-c2ccccc2)cc1)c1ccc(F)c(NC(=O)c2ccccc2-c2ccccc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.57
▸ CHRNB2 P17787 1/20 0.56
▸ CHRNB4 P30926 1/20 0.56
▸ CHRNA3 P32297 1/20 0.56
▸ CHRNA4 P43681 1/20 0.56
▸ MAPT P10636 1/20 0.53
▸ HDAC1 Q13547 3/20 0.53
▸ EPHX2 P34913 2/20 0.52
▸ NR1H4 Q96RI1 2/20 0.52
▸ EGFR P00533 1/20 0.52
▸ HDAC7 Q8WUI4 2/20 0.51
▸ HDAC3 O15379 1/20 0.51
▸ HDAC4 P56524 1/20 0.51
▸ HDAC2 Q92769 1/20 0.51
▸ HDAC10 Q969S8 1/20 0.51
▸ HDAC11 Q96DB2 1/20 0.51
▸ HDAC8 Q9BY41 1/20 0.51
▸ HDAC6 Q9UBN7 1/20 0.51
▸ HDAC9 Q9UKV0 1/20 0.51
▸ HDAC5 Q9UQL6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7616965 0.87 HDAC8 (0.57) CHRNB2CHRNB4CHRNA3CHRNA4MAPT
SCHEMBL7607157 0.81 TP53 (0.65) HTTCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7610932 0.81 CHRNB2 (0.60) HTTCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7607213 0.81 HTT (0.61) HTTCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7611172 0.77 HTT (0.57) HTTCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7610512 0.77 L3MBTL1 (0.61) HTTCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7612211 0.77 NR1H4 (0.62) HDAC1EPHX2NR1H4EGFRHDAC7
SCHEMBL7606402 0.76 MTTP (0.57) HTTCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7609363 0.76 MTTP (0.57) HTTCHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL7611070 0.76 CHRNB2 (0.56) HTTCHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments MTTP, CETP, FABP1 HTT 3107/4885CHRNB2 4877/4885CHRNB4 4881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback